Closer to detecting preeclampsia: Biomarkers found in urine, blood — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140317174500.htm
source : http://www.sciencedaily.com/releases/2014/03/140317174500.htm
source : http://www.sciencedaily.com/releases/2014/03/140309150331.htm
source : http://www.sciencedaily.com/releases/2014/03/140307100123.htm
source : http://www.sciencedaily.com/releases/2014/02/140219142357.htm
source : http://www.sciencedaily.com/releases/2014/02/140212112741.htm
Minimally invasive techniques — such as fine-needle aspiration or circulating tumor cell analysis — are increasingly employed to track treatment response over time in clinical trials, as such tests can be simple and cheap to perform. …
CTCs can also be tested to identify genetic mutations associated with a tumor. Many newer cancer medications are designed to target specific genetic mutations, so they work best for limited types and stages of cancer. CTCs can provide a quick method to help physicians choose the most appropriate targeted therapy for a particular patient…
The method uses a drug which breaks down the protective barrier surrounding pancreatic cancer tumors, enabling cancer-attacking T cells to get through. The drug is used in combination with an antibody that blocks a second target, which improves the activity of these T cells. Initial tests of the combined treatment, carried out by researchers at the University’s Cancer Research UK Cambridge Institute, resulted in almost complete elimination of cancer cells in one week. The findings, reported in the journal PNAS, mark the first time this has been achieved in any pancreatic cancer model. …
Diagnosis: colon cancer Today pathologists slice tissue obtained from biopsies into thin sections, stain them chemically, and eventually identify colon cancer by visual inspection under the microscope. This is usually done at an advanced stage of the disease, and the method provides no information about the molecular causes of the tumour. …
It is a genomic-clinical method able to determinate the prognosis of a patient with lung adenocarcinoma by studying the expression levels of 30 genes and combining the results with other indicators such as age, gender or the stage of the tumor. From this study, patients are classified into phases and from this classification depends their prognosis and treatment…